Hamid Ganji

Hamid Ganji

Auto-generated profile, based on publicly available information

Hamid Ganji

Medical Genetics Laboratory, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Research Focus & Metrics

Academic Career Length

59Years (1968-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1968
Verified
Journal Article
Closed access
WBW F Becker
W F Becker
HPH S Pratt
H S Pratt
HGH Ganji
H Ganji

1 January 2014 in Advanced Biomedical Research
Verified
Journal Article
Open access
PDF file
NNNayereh Nouri
Nayereh Nouri
MSMaryam Sedghi
Maryam Sedghi
MBMahdiyeh Behnam
Mahdiyeh Behnam
EFEsmat Fazel
Esmat Fazel
MSMansoor Salehi
Mansoor Salehi
MHMajid Hosseinzadeh
Majid Hosseinzadeh
Background: Proximal spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by symmetrical proximal muscle weakness and atrophy. According to the severity of the disease and the age of onset, SMA can be divided into three groups. The survival motor neuron (SMN) gene that is located on 5q13 is identified as the disease determining gene. Another gene in this region is neuronal apoptosis inhibitory protein (NAIP), and its functional role in the pathogenesis of SMA has not been fully elucidated. Here, we investigated the correlation between deletions in SMN and NAIP genes with clinical features of SMA patients. Materials and Methods: In the current study, 71 unrelated Iranian patients were investigated for the detection of deletions in SMN1 and NAIP genes. Polymerase chain reaction (PCR) was used to detect the deletions of exon 4 and 5 of the NAIP gene. Deletions in exon 7 and 8 of SMN1 gene were detected by RFLP-PCR with DraI and DdeI, respectively. Results: Our results showed that 51 patients have homozygous deletions in SMN1 and/or NAIP genes. Among these 51 patients, deletion in NAIP gene were found in 35 patients (65.7% of type I, 22.5% type II and 11.42% type III). Conclusion: Defect in SMN1 gene plays a major role in manifesting of the disease and NAIP (4 and 5) gene acts as a modifying factor in severity of symptoms. Correlation between NAIP gene defect and severity of the disease is confirmed. However, the exact role of NAIP gene in SMA has yet to be fully clarified.

20 February 2014 in Journal of Child Neurology
Verified
Journal Article
Closed access
HGHamid Ganji
Hamid Ganji
NNNayereh Nouri
Nayereh Nouri
MSMansoor Salehi
Mansoor Salehi
OAOmid Aryani
Omid Aryani
MHMassoud Houshmand
Massoud Houshmand
MSMaryam Sedghi
Maryam Sedghi
Proximal spinal muscular atrophy is an autosomal recessive disorder characterized by symmetrical muscle weakness due to degeneration of alpha motor neurons in the spinal cord. Homozygous deletions in the SMN1 have been reported in more than 90% of spinal muscular atrophy cases. Compound heterozygous patients account for approximately 4% of spinal muscular atrophy cases. In this study, we performed a quantitative test in 20 of 87 spinal muscular atrophy patients who did not have homozygous deletion of SMN1. Mutation screening of SMN1 gene was performed in 4 patients who have only 1 copy of SMN1 to identify intragenic mutations. In addition to a previously described missense mutation in exon 4 (p.A188S/ c.562G>T), we identified 2 novel mutations including a single nucleotide insertion in exon 7 (c.861_862insT/p.R288X) and a deletion of nucleotide G in exon 3 (c.286delG/p.D96Tfs*53). Our results suggested that about 4% of spinal muscular atrophy patients have subtle mutations and might be considered in laboratory examination.

1 May 2012
Verified
Journal Article
Open access
HYHojatollah Yousefi
Hojatollah Yousefi
AKAfsaneh Karami
Afsaneh Karami
MMMahin Moeini
Mahin Moeini
HGHamid Ganji
Hamid Ganji
Since the family is a social system, the impairment in each of its component members may disrupt the entire family system. One of the stress sources for families is accidents leading to hospitalization particularly in the intensive care unit (ICU). In many cases, the families’ needs in patient care are not met that cause dissatisfaction. Since the nurses spend a lot of time with patients and their families, they are in a good position to assess their needs and perform appropriate interventions. Therefore, this study was conducted to determine the effectiveness of nursing interventions based on family needs on family satisfaction level of hospitalized patients in the neurosurgery ICU. This clinical trial was conducted in the neurosurgery ICU of Al-Zahra Hospital, Isfahan, Iran in 2010. Sixty four families were selected by simple sampling method and were randomly placed in two groups (test and control) using envelopes. In the test group, some interventions were performed to meet their needs. In the control group, the routine actions were only carried out. The satisfaction questionnaire was completed by both groups two days after admission and again on the fourth day. Both of the intervention and control groups were compared in terms of the mean satisfaction scores before and after intervention. There was no significant difference in mean satisfaction scores between test and control groups before the intervention. The mean satisfaction score significantly increased after the intervention compared to the control group. Nursing interventions based on family needs of hospitalized patients in the ICU increase their satisfaction. Attention to family nursing should be planned especially in the ICUs.

1 January 2015 in Advanced Biomedical Research
Verified
Journal Article
Open access
PDF file
LDLeila Dehghani
Leila Dehghani
MEMasoud Etemadifar
Masoud Etemadifar
HGHamid Ganji
Hamid Ganji
RSReza Soleimani
Reza Soleimani
MTMaedeh Talebi
Maedeh Talebi
RMRokhsareh Meamar
Rokhsareh Meamar
Background: Endothelial progenitor cells (EPCs) are present in circulation and contribute to vasculogenesis in adults. The aim of the present study was to determine the number of circulating EPCs in patients with optic neuritis (ON). Materials and Methods : Fifty patients with ON were diagnosed by expert neurologist and optometrist at the Feiz Hospital, Isfahan, Iran (2012-2013). Blood samples were collected from ON patients in the first attack. The number of EPCs was measured by flow cytometry through the assessment of CD34 + and CD309 + in patients and healthy individuals. Results : With using flow cytometry, CD34 + and CD309 + cells detected in peripheral blood cells of patients (n = 50) with ON, and healthy individuals (n = 30). Patients with ON had (mean = 66.71 ± 17.82) CD34 + and CD309 + cells compared with healthy controls (mean = 28.72 ± 22.46). In addition, there was no significant difference in CD309 + cells in both groups. Conclusion: This study showed elevated CD34 + and CD309 + cells in the early stage of the disease. Regarded to EPC increment in neural repair, it expected the EPC level be increased in these patients, but no detectable differences were observed among both markers in healthy and patient with first attack.

12 September 2013 in Heart Asia
Verified
Journal Article
Closed access
PDF file
HGHamid Ganji
Hamid Ganji
MSMansoor Salehi
Mansoor Salehi
MSMaryam Sedghi
Maryam Sedghi
HAHossein Abdali
Hossein Abdali
NNNayereh Nouri
Nayereh Nouri
MLMahdi Lotfi
Mahdi Lotfi
Background DiGeorge syndrome (DGS) is the result of a microdeletion in chromosome 22q11.2 in over 90% of cases. DGS is the second most frequent syndrome after Down syndrome and has an incidence of 1/4000 births. Unequal crossover between low-copy repeats, on the proximal part of the long arm of chromosome 22, usually results in a 3 Mb deletion in one of the chromosome 22 and a reciprocal and similarly sized duplication on the other one. Several studies have indicated that TBX1 (T-box 1) haploinsufficiency is responsible for many of the phenotypic traits of 22q11.2 deletion syndrome. Conotruncal heart defects (CTDs) are present in 75–85% of patients with 22q11.2 deletion syndrome in Western countries. Methods Among 78 patients fulfilling the criteria for DGS diagnosed by the fluorescence in situ hybridisation test, 24 had 22q11.2 deletion. Screening for TBX1 gene deletion was performed by multiplex ligation-dependent probe amplification (MLPA). Results Our results revealed that of 24 patients with TBX1 gene deletion, 12 had CTDs while 12 did not show any heart defects. Conclusions Our findings indicate that other genes or gene interactions may play a role in penetrance or the severity of heart disease among patients with DGS.